Autologous Adult Stem Cell Induced-Lymphangiogenesis in Peripheral Lymphedema

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201202209083N1

Enrollment

Registered

2012-03-12

Start date

2012-02-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoedema. Lymphoedema, not elsewhere classified

Interventions

1) Bone Marrow Aspiration 2) Detachment Precursur Cell Endothelial with CLINIMACS Cell S??eparator System 3) Cell Culture 4) Injection Subcutanens in Local Specific.

Treatment - Surgery

1) Bone Marrow Aspiration 2) Detachment Precursur Cell Endothelial with CLINIMACS Cell S??eparator System 3) Cell Culture 4) Injection Subcutanens in Local Specific

Eligibility

Sex/Gender

All

Age

16 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion:/ Congential Atresia or Hypoplasia of Lymphatic Vesseles Exclusion Criteria :/Inflamatory Malignant Disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Diametr of Organ. Timepoint: 15 day, 1 m, 3m, 6m, 12m. Method of measurement: Centimeter.;Lymphosentigraphy. Timepoint: 15 day, 1 m, 3m, 6m, 12m. Method of measurement: Lymphosentigraphy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Habib Allah Peirovi

Nano Medicine& Tissue Engineering Research Center (Shahid Beheshti of Medical University)

dhpsurgery@sbmu.ac.ir+98 21 2243 9848

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026